Description

Morniflumate is a non-steroidal anti-inflammatory drug (NSAID) belonging to the fenamate class, specifically identified by CAS NO 65847-85-0. This compound is valued for its potent anti-inflammatory and analgesic properties, making it a key intermediate in advanced pharmaceutical synthesis. It is primarily required by manufacturers in the pharmaceutical industry for the development and production of prescription medications targeting inflammation and pain management.

Application

• Pharmaceutical Intermediate: Primary use as a critical building block in the synthesis of prescription anti-inflammatory drugs.
• Active Pharmaceutical Ingredient (API) Production: Manufacture of finished dosage forms such as tablets and capsules.
• Research & Development: Utilized in preclinical and clinical studies for developing new therapeutic agents.
• Veterinary Medicine: Potential application in anti-inflammatory treatments for animals.
• Reference Standard: Serves as a high-purity standard for quality control and analytical testing in laboratories.

Basic Information

Product Name	Morniflumate
CAS No.	65847-85-0
Molecular Formula	C20H20F3N3O5
Molecular Weight	439.39 g/mol
Synonyms	Morniflumate; 2-[[3-(Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid compound with 4-morpholineethanol (1:1); 4-Morpholineethanol, compound with 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid (1:1); Morniflumato [INN-Spanish]; Morniflumatum [INN-Latin]; UR 652
EINECS	Contact for details

Quality Control

Our Morniflumate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. The product is tested against rigorous in-house specifications, which typically include identification, assay, and impurity profile analysis. Certificates of Analysis (COA) detailing the results are available upon request to support your quality assurance and regulatory compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.